Hot Life Science Investor Mandate 3: Swedish VC Fund Seeking Clinical Stage Therapeutics Throughout Europe

5 Mar

A Swedish venture capital fund that invests in life science companies with a focus on therapeutics is currently seeking new opportunities. The firm has raised six funds to date, with the most recent fund size of €110M (2011 vintage). The firm can allocate up to €10-15M per company and typically provides equity as well as debt financing. The firm generally acts as the lead or co-lead investor and is open to invest in syndicates. Currently, the firm seeks to invest in companies that are based in the European Union or US company that is open to establish an EU entity.

The firm is currently seeking to invest in early to mid stage biotech therapeutics and pharmaceuticals. The firm is also interested in exceptional medical devices with a therapeutic application that is close to market or has generated some sales. The firm is opportunistic across the therapeutic subsectors but prefers products that target niche indications.  Currently, the firm is more interested in oncology and orphan indications.  The firm looks for products with proofs of concept in Phase I and II.

The firm requests a board seat in each portfolio company. The firm seeks a strong and experienced management team.

If you are interested in more information about this investor and other investors tracked by LSN, please email

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: